CGEN vs CERS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CGEN Captures Institutional Edge (3โ1 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Compugen Ltd (CGEN) driven by superior Valuation, Growth & Margin, Momentum & Technical while CERS counters with relative strength in Options & Structure. Fundamentally, CGEN trades at 12.4x Forward P/E with 41.3% operating margin (+102.1% YoY revenue) versus CERS at 126.7x Forward P/E and -1.1% operating margin (+9.5% YoY). In options structure, CGEN sits in BREAKDOWN (57th %ile IV; Dealer Gamma Walls on Pro) against CERS sits in BREAKDOWN (20th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CGEN Revenue | CERS Revenue | CGEN Op. Margin | CERS Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $20M | $80M | -130.5% | -72.3% | CERS |
| FY2019 | N/A | $90M | N/A | -70.6% | CERS |
| FY2020 | $0M | $110M | -1574.8% | -51.1% | CERS |
| FY2021 | $10M | $160M | -584.6% | -30.7% | CERS |
| FY2022 | $10M | $190M | -471.7% | -18.1% | CERS |
| FY2023 | $30M | $190M | -38.8% | -16.1% | CERS |
| FY2024 | $30M | $200M | -53.4% | -7.1% | CERS |
| FY2025 | $70M | $230M | 43.1% | -3.7% | CGEN |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CGEN | CERS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $193.2M | $375.6M | Larger Scale | CERS |
| Trailing P/E Ratio Valuation | 5.2x | N/M | Lower Multiple | CGEN |
| Forward P/E Ratio Valuation | 12.4x | 126.7x | Lower Multiple | CGEN |
| Revenue Growth (YoY) Growth | +102.1% | +9.5% | Higher Growth | CGEN |
| Operating Margin (TTM) Profitability | 41.3% | -1.1% | Higher Margin | CGEN |
| Net Profit Margin Profitability | 47.9% | -3.2% | Higher Margin | CGEN |
| Return on Equity (ROE) Capital Efficiency | 57.2% | -10.7% | Higher ROE | CGEN |
| 52-Week Range Position Momentum | 33% ($1โ$3) | 22% ($1โ$3) | Stronger Trend | CGEN |
| Beta / 30D Volatility Risk Regime | 1.44ฮฒ ยท 62% Vol | 1.62ฮฒ ยท 78% Vol | Lower Realized Risk | CGEN |
| Unified Institutional Score Composite Signal | 47.1 / 100 (HOLD) | 54.4 / 100 (HOLD) | Higher Composite | CERS |